Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.
Hematol Oncol
; 38(3): 412-414, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32323881
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Translocation, Genetic
/
Chromosomes, Human, Pair 11
/
Chromosomes, Human, Pair 14
/
Antineoplastic Combined Chemotherapy Protocols
/
Multiple Myeloma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hematol Oncol
Year:
2020
Document type:
Article
Affiliation country:
Czech Republic
Country of publication:
United kingdom